Tissue response curve‐shape analysis of dynamic glucose‐enhanced and dynamic contrast‐enhanced magnetic resonance imaging in patients with brain tumor

Dynamic glucose‐enhanced (DGE) MRI is used to study the signal intensity time course (tissue response curve) after D‐glucose injection. D‐glucose has potential as a biodegradable alternative or complement to gadolinium‐based contrast agents, with DGE being comparable with dynamic contrast‐enhanced (DCE) MRI. However, the tissue uptake kinetics as well as the detection methods of DGE differ from DCE MRI, and it is relevant to compare these techniques in terms of spatiotemporal enhancement patterns. This study aims to develop a DGE analysis method based on tissue response curve shapes, and to investigate whether DGE MRI provides similar or complementary information to DCE MRI. Eleven patients with suspected gliomas were studied. Tissue response curves were measured for DGE and DCE MRI at 7 T and the area under the curve (AUC) was assessed. Seven types of response curve shapes were postulated and subsequently identified by deep learning to create color‐coded “curve maps” showing the spatial distribution of different curve types. DGE AUC values were significantly higher in lesions than in normal tissue (p < 0.007). Furthermore, the distribution of curve types differed between lesions and normal tissue for both DGE and DCE. The DGE and DCE response curves in a 6‐min postinjection time interval were classified as the same curve type in 20% of the lesion voxels, which increased to 29% when a 12‐min DGE time interval was considered. While both DGE and DCE tissue response curve‐shape analysis enabled differentiation of lesions from normal brain tissue in humans, their enhancements were neither temporally identical nor confined entirely to the same regions. Curve maps can provide accessible and intuitive information about the shape of DGE response curves, which is expected to be useful in the continued work towards the interpretation of DGE uptake curves in terms of D‐glucose delivery, transport, and metabolism.

[1]  T. Jin,et al.  Quantitative kinetic modelling and mapping of cerebral glucose transport and metabolism using glucoCESL MRI , 2022, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  P. V. van Zijl,et al.  Imaging of sugar‐based contrast agents using their hydroxyl proton exchange properties , 2022, NMR in biomedicine.

[3]  K. Scheffler,et al.  GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas , 2021, Magnetic Resonance Materials in Physics, Biology and Medicine.

[4]  Nirbhay N. Yadav,et al.  Towards robust glucose chemical exchange saturation transfer imaging in humans at 3 T: Arterial input function measurements and the effects of infusion time , 2021, NMR in biomedicine.

[5]  Celia M. Dong,et al.  Altered d-glucose in brain parenchyma and cerebrospinal fluid of early Alzheimer’s disease detected by dynamic glucose-enhanced MRI , 2020, Science Advances.

[6]  Jennifer M. Coughlin,et al.  d‐glucose weighted chemical exchange saturation transfer (glucoCEST)‐based dynamic glucose enhanced (DGE) MRI at 3T: early experience in healthy volunteers and brain tumor patients , 2019, Magnetic resonance in medicine.

[7]  Klaus Scheffler,et al.  T1ρ‐based dynamic glucose‐enhanced (DGEρ) MRI at 3 T: method development and early clinical experience in the human brain , 2019, Magnetic resonance in medicine.

[8]  David Fuentes,et al.  Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging , 2019, Neuro-oncology.

[9]  Klaus Scheffler,et al.  Possible artifacts in dynamic CEST MRI due to motion and field alterations. , 2019, Journal of magnetic resonance.

[10]  Karin Markenroth Bloch,et al.  Arterial Input Functions and Tissue Response Curves in Dynamic Glucose-Enhanced (DGE) Imaging: Comparison Between glucoCEST and Blood Glucose Sampling in Humans , 2018, Tomography.

[11]  Tao Jin,et al.  Chemical exchange–sensitive spin‐lock (CESL) MRI of glucose and analogs in brain tumors , 2018, Magnetic resonance in medicine.

[12]  Daniel Paech,et al.  Fast and Quantitative T1ρ-weighted Dynamic Glucose Enhanced MRI , 2017, Scientific Reports.

[13]  Anna Fabijanska,et al.  A novel approach for quantification of time-intensity curves in a DCE-MRI image series with an application to prostate cancer , 2016, Comput. Biol. Medicine.

[14]  Andrea Bergmann,et al.  Statistical Parametric Mapping The Analysis Of Functional Brain Images , 2016 .

[15]  Jiadi Xu,et al.  Dynamic glucose enhanced (DGE) MRI for combined imaging of blood–brain barrier break down and increased blood volume in brain cancer , 2015, Magnetic resonance in medicine.

[16]  Robert D. Stevens,et al.  Dynamic Glucose-Enhanced (DGE) MRI: Translation to Human Scanning and First Results in Glioma Patients , 2015, Tomography.

[17]  Amy C. Dwyer,et al.  Models and methods for analyzing DCE-MRI: a review. , 2014, Medical physics.

[18]  John C Gore,et al.  Measurement of regional cerebral glucose uptake by magnetic resonance spin-lock imaging. , 2014, Magnetic resonance imaging.

[19]  Jiadi Xu,et al.  Natural D‐glucose as a biodegradable MRI relaxation agent , 2014, Magnetic resonance in medicine.

[20]  Tao Jin,et al.  Mapping brain glucose uptake with chemical exchange-sensitive spin-lock magnetic resonance imaging , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Xavier Golay,et al.  Imaging Brain Deoxyglucose Uptake and Metabolism by Glucocest MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  Cristina Lavini,et al.  Use of dynamic contrast enhanced time intensity curve shape analysis in MRI: theory and practice , 2013 .

[23]  Mark F. Lythgoe,et al.  In vivo imaging of glucose uptake and metabolism in tumors , 2012, Nature Medicine.

[24]  Yoshinori Kato,et al.  Natural D‐glucose as a biodegradable MRI contrast agent for detecting cancer , 2012, Magnetic resonance in medicine.

[25]  Thomas E. Yankeelov,et al.  Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation , 2012, Pharmaceutics.

[26]  Cristina Lavini,et al.  Model‐based, semiquantitative and time intensity curve shape analysis of dynamic contrast‐enhanced MRI: A comparison in patients undergoing antiangiogenic treatment for recurrent glioma , 2011, Journal of magnetic resonance imaging : JMRI.

[27]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[28]  Thomas E Yankeelov,et al.  Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. , 2007, Current medical imaging reviews.

[29]  Hiroshi Honda,et al.  Enhanced mass on contrast‐enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast‐enhanced and diffusion‐weighted MR images , 2008, Journal of magnetic resonance imaging : JMRI.

[30]  Hai-Ling Margaret Cheng,et al.  Investigation and optimization of parameter accuracy in dynamic contrast‐enhanced MRI , 2008, Journal of magnetic resonance imaging : JMRI.

[31]  Sang Ho Lee,et al.  Texture analysis of lesion perfusion volumes in dynamic contrast-enhanced breast MRI , 2008, 2008 5th IEEE International Symposium on Biomedical Imaging: From Nano to Macro.

[32]  Cristina Lavini,et al.  Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. , 2007, Magnetic resonance imaging.

[33]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.

[34]  O. Paulson,et al.  Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. , 2001, The Journal of clinical endocrinology and metabolism.

[35]  J L Evelhoch,et al.  Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.

[36]  R Gruetter,et al.  Lactate turnover in rat glioma measured by in vivo nuclear magnetic resonance spectroscopy. , 1998, Cancer research.

[37]  C T W Moonen,et al.  Determination of cerebral glucose transport and metabolic kinetics by dynamic MR spectroscopy. , 1997, American journal of physiology. Endocrinology and metabolism.

[38]  Jürgen Schmidhuber,et al.  Long Short-Term Memory , 1997, Neural Computation.

[39]  J. Gore,et al.  Influence of glycogen on water proton relaxation times , 1986, Magnetic resonance in medicine.